Orchestra BioMed
OBIO
#8900
Rank
HK$0.82 B
Marketcap
HK$21.46
Share price
-11.25%
Change (1 day)
-44.86%
Change (1 year)

Orchestra BioMed (OBIO) - Cash on Hand

Cash on Hand as of September 2024 : HK$0.52 Billion

According to Orchestra BioMed 's latest financial reports the company has HK$0.52 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Orchestra BioMed - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.68 B4.5%
2022-12-31HK$0.65 B670.5%
2021-12-31HK$84.96 M-69.38%
2020-12-31HK$0.27 B